Literature DB >> 21348301

[Mangiferin promotes uric acid excretion and kidney function improvement and modulates related renal transporters in hyperuricemic mice].

Qing-hua Hu1, Xian Zhang, Yu Wang, Ling-dong Kong.   

Abstract

The effects of mangiferin on uric acid excretion, kidney function and related renal transporters were investigated in hyperuricemic mice induced by potassium oxonate. Mice were divided into normal control group, and 5 hyperuricemic groups with model control, 50, 100, and 200 mg x kg(-1) mangiferin, and 5 mg x kg(-1) allopurinol. Mice were administered by gavage once daily with 250 mg x kg(-1) potassium oxonate for seven consecutive days to create the model. And 3 doses of mangiferin were orally initiated on the day 1 h after potassium oxonate was given, separately. Serum uric acid, creatinine and urea nitrogon levels, as well as urinary uric acid creatinine levels were measured. Mouse uromodulin (mUMOD) levels in serum, urine and kidney were determined by ELISA method. The mRNA and protein levels of related renal transporters were assayed by RT-PCR and Western blotting methods, respectively. Compared to model group, mangiferin significantly reduced serum uric acid, creatinine and urea nitrogon levels, increased 24 h uric acid and creatinine excretion, and fractional excretion of uric acid in hyperuricemic mice, exhibiting uric acid excretion enhancement and kidney function improvement. Mangiferin was found to down-regulate mRNA and protein levels of urate transporter 1 (mURAT1) and glucose transporter 9 (mGLUT9), as well as up-regulate organic anion transporter 1 (mOAT1) in the kidney of hyperuricemic mice. These findings suggested that mangiferin might enhance uric acid excretion and in turn reduce serum uric acid level through the decrease of uric acid reabsorption and the increase of uric acid secretion in hyperuricemic mice. Moreover, mangiferin remarkably up-regulated expression levels of renal organic cation and carnitine transporters (mOCT1, mOCT2, mOCTN1 and mOCTN2), increased urine mUMOD levels, as well as decreased serum and kidney mUMOD levels in hyperuricemic mice, which might be involved in mangiferin-mediated renal protective action.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21348301

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  6 in total

1.  Potassium oxonate induces acute hyperuricemia in the tree shrew (tupaia belangeri chinensis).

Authors:  Dong-Hong Tang; You-Song Ye; Chen-Yun Wang; Zhe-Li Li; Hong Zheng; Kai-Li Ma
Journal:  Exp Anim       Date:  2017-03-16

Review 2.  Mangiferin: a natural miracle bioactive compound against lifestyle related disorders.

Authors:  Muhammad Imran; Muhammad Sajid Arshad; Masood Sadiq Butt; Joong-Ho Kwon; Muhammad Umair Arshad; Muhammad Tauseef Sultan
Journal:  Lipids Health Dis       Date:  2017-05-02       Impact factor: 3.876

3.  Therapeutic effects and mechanisms of N-(9,10-anthraquinone-2-ylcarbonyl) xanthine oxidase inhibitors on hyperuricemia.

Authors:  Tianshu Gao; Jin Xu; Yuxiao Xiao; Jiaqi Li; Weifeng Hu; Xiaoyu Su; Xudong Shen; Wan Yu; Zhen Chen; Baosheng Huang; Honglei Li; Xing Wang
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

4.  Protective effects of corni fructus extract in mice with potassium oxonate-induced hyperuricemia.

Authors:  Chih-Chiang Wang; You-Liang Li; Po-Yen Chiu; Chun Chen; Hung-Che Chen; Fu-An Chen
Journal:  J Vet Med Sci       Date:  2022-07-04       Impact factor: 1.105

5.  Portulaca oleracea L. alleviates liver injury in streptozotocin-induced diabetic mice.

Authors:  Guoyin Zheng; Fengfeng Mo; Chen Ling; Hao Peng; Wei Gu; Min Li; Zhe Chen
Journal:  Drug Des Devel Ther       Date:  2017-12-28       Impact factor: 4.162

6.  Antihyperuricemic effect of mangiferin aglycon derivative J99745 by inhibiting xanthine oxidase activity and urate transporter 1 expression in mice.

Authors:  Zhizhen Qin; Shoubao Wang; Yihuang Lin; Ying Zhao; Shengqian Yang; Junke Song; Tao Xie; Jinlong Tian; Song Wu; Guanhua Du
Journal:  Acta Pharm Sin B       Date:  2017-07-29       Impact factor: 11.413

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.